MoneyWorks4Me

Aurobindo Pharma board to consider financial results

23 Oct 2012 Evaluate
Aurobindo Pharma has informed that a meeting of the board of directors of the company will be held on November 09, 2012, to consider the un-audited financial results of the company for the quarter and half year ended September 30, 2012 (Q2).

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..